Total Payments
$2,651
2024 Payments
$1,826
Companies
23
Transactions
144
Medicare Patients
1,590
Medicare Billing
$90,076
Payment Breakdown by Category
Food & Beverage$2,651 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,651 | 144 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $584.12 | 23 | $0 (2024) |
| Lilly USA, LLC | $316.98 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $279.38 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $196.56 | 10 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $168.75 | 7 | $0 (2024) |
| Novo Nordisk Inc | $165.38 | 10 | $0 (2024) |
| PFIZER INC. | $120.75 | 7 | $0 (2024) |
| Amgen Inc. | $102.69 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $93.63 | 5 | $0 (2024) |
| Exact Sciences Corporation | $91.03 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,826 | 91 | ABBVIE INC. ($371.44) |
| 2023 | $824.44 | 53 | ABBVIE INC. ($212.68) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: VACCINE | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Biological | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: DIABETES | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Neurology | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: GI | ||||||
| 09/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Insomnia | ||||||
| 09/19/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: Insomnia | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 900 | 1,556 | $172,032 | $36,412 |
| 2022 | 3 | 240 | 246 | $256,313 | $18,857 |
| 2021 | 3 | 270 | 277 | $289,115 | $23,021 |
| 2020 | 3 | 180 | 183 | $144,571 | $11,786 |
Total Patients
1,590
Total Services
2,262
Medicare Billing
$90,076
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 472 | 690 | $95,910 | $27,545 | 28.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 37 | 37 | $39,304 | $2,646 | 6.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 53 | 56 | $4,480 | $2,271 | 50.7% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 15 | 15 | $23,338 | $1,482 | 6.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 25 | 54 | $1,674 | $875.88 | 52.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 72 | $4,248 | $565.14 | 13.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 43 | $473.00 | $361.20 | 76.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 39 | 39 | $780.00 | $296.79 | 38.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 79 | 95 | $855.00 | $295.45 | 34.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 54 | 440 | $880.00 | $39.72 | 4.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 15 | $90.00 | $33.00 | 36.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 70 | 71 | $107,987 | $7,958 | 7.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 104 | 107 | $110,677 | $7,950 | 7.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 66 | 68 | $37,649 | $2,948 | 7.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 96 | 98 | $143,994 | $11,502 | 8.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 106 | 107 | $107,152 | $8,283 | 7.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 68 | 72 | $37,969 | $3,236 | 8.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 69 | 71 | $64,748 | $5,095 | 7.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 30 | 30 | $40,401 | $3,452 | 8.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 81 | 82 | $39,422 | $3,238 | 8.2% |
About Kaelyn Lay, MSN, APRN
Kaelyn Lay, MSN, APRN is a Family healthcare provider based in North Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1962948075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kaelyn Lay, MSN, APRN has received a total of $2,651 in payments from pharmaceutical and medical device companies, with $1,826 received in 2024. These payments were reported across 144 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,651).
As a Medicare-enrolled provider, Lay has provided services to 1,590 Medicare beneficiaries, totaling 2,262 services with total Medicare billing of $90,076. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location North Little Rock, AR
- Active Since 01/12/2017
- Last Updated 09/18/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962948075
Products in Payments
- UBRELVY (Drug) $242.71
- AIRSUPRA (Drug) $220.21
- MOUNJARO (Drug) $192.81
- VRAYLAR (Drug) $178.65
- JARDIANCE (Drug) $173.63
- QUVIVIQ (Drug) $168.75
- QULIPTA (Drug) $134.16
- NURTEC ODT (Drug) $103.28
- SPRAVATO (Drug) $93.63
- Cologuard Collection Kit (Device) $91.03
- Kerendia (Drug) $87.42
- TRELEGY ELLIPTA (Drug) $76.96
- OFEV (Drug) $76.80
- EVENITY (Biological) $72.45
- FARXIGA (Drug) $59.17
- Ozempic (Drug) $55.45
- VOQUEZNA (Drug) $48.78
- XIFAXAN (Drug) $42.61
- FREESTYLE LIBRE 3 (Device) $40.24
- GEMTESA (Drug) $36.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in North Little Rock
Kimberly Gates, Aprn, APRN
Family — Payments: $16,977
Family $16,977
Morgan Hayes, Aprn, APRN
Family — Payments: $5,750
Family $5,750
Angela Cheves, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $3,951
Family $3,951
Jessica Morrow, Aprn, APRN
Family — Payments: $3,351
Family $3,351
Kristin Green, Fnp-C, FNP-C
Family — Payments: $2,384
Family $2,384
Mrs. Lydia Williams, Aprn, APRN
Family — Payments: $2,033
Family $2,033